NovoMed Zielinski i Wspolnicy Spolka Jawna

Katowice 40-650

0 studies enrolling now · 2 studies all time

What they study most

Partial Epilepsy, Relapsing Multiple Sclerosis

Studies at this site

• A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures — Completed
• Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis — Completed